Sanofi opens the books – that’s what analysts expect.
Sanofi will present the quarterly figures for the most recent quarter – closing date September 30, 2023 – at the financial conference on October 27th, 2023.
On average, 9 analysts forecast earnings per share of EUR 2.60 compared to EUR 2.88 in the same quarter of the previous year.
The average estimates of 9 analysts for sales for the past quarter are EUR 12.47 billion – this would correspond to a minus of 5.06 percent compared to the same quarter of the previous year, in which EUR 13.14 billion were on the books.
18 analysts estimate an average profit of EUR 8.25 per share for the current fiscal year. In the previous year, EUR 8.26 per share was earned. In terms of sales, 17 analysts expect an average of EUR 45.20 billion for the current fiscal year, compared to EUR 45.39 billion in the same period last year.
Editorial team finanzen.net
Selected leverage products on Sanofi
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Sanofi
The leverage must be between 2 and 20
Advertising